References
- Sulser F., Janowsky A J, Okada F, Manier D H, Mobley P L. Regulation of recognition and action function of the norepinephrine (NE) receptor-coupled adenylate cyclase system in the brain: Implication for the therapy of depression. Neuropharmacol 1983; 22: 425–31
- Ebstein R P, Hermoni M, Belmaker R H. The effect of lithium on noradrenaline-induced cyclic AMP accumulation in rat brain; inhibition after chronic treatment and absence of supersensitivity. J Pharmacol Exp Ther 1980; 213: 161–7
- Geisler A, Klysner R. The effect of lithium in vitro and in vivo on dopamine-sensitive adenylate cyclase activity in dopaminergic areas of the rat brain. Acta Pharmacol toxicol 1985; 56: 1–5
- Hotta I, Yamawaki S. Lithium decreases 5-HT1 receptors but increases 5-HT-sensitive adenylate cyclase activity in rat hippocampus. Biol Psychiatry 1986; 21: 1382–90
- Fossel E T, Sarasua M M, Koehler K A. A lithium-7 NMR investigation of the lithium ion interaction with phosphatidylcholine-phosphatidylglycerol membranes. Observation of calcium and magnesium ion competition. J Magnetic Resonance 1985; 64: 536–40
- Meltzer H L. Lithium mechanism in bipolar illness and altered intracellular calcium functions. Biol Psychiatry 1986; 21: 492–510
- Mørk A, Geisler A. Effects of lithium on calmodulinstimulated adenylate cycklase activity in cortical membranes from rat brain. Pharmacol Toxicol 1987; 60: 17–23
- Mørk A, Geisler A. Mode of action of lithium on the catalytic unit of adenylat cyclase from rat brain. Pharmacol Toxicol 1987; 60: 241–8